Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

[A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer].

Wada T, Nishide T, Hatayama K, Chang SW, Tatsuta M, Yasutomi M.

Gan To Kagaku Ryoho. 1987 Aug;14(8):2509-12. Japanese.

PMID:
3113339
2.

[Results of phase III study of lentinan].

Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Itoh I, Ogawa N.

Gan To Kagaku Ryoho. 1985 Feb;12(2):366-78. Japanese.

PMID:
3918510
3.

[Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group].

Wakui A, Kasai M, Konno K, Abe R, Kanamaru R, Takahashi K, Nakai Y, Yoshida Y, Koie H, Masuda H, et al.

Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):1050-9. Japanese.

PMID:
3083785
4.

[TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].

Nagahashi S, Suzuki H, Nishiwaki M, Okuda K, Kurosawa Y, Terada S, Sugihara T, Andou K, Hibi T.

Gan To Kagaku Ryoho. 2004 Nov;31(12):1999-2003. Japanese.

PMID:
15570928
5.
6.

[Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers].

Wada T, Matunami N, Houjou T, Morikawa E, Mori N, Nakano K, Aizawa M, Kurooka K, Kadota K, Yamato M, et al.

Gan To Kagaku Ryoho. 1989 May;16(5):2087-92. Japanese.

PMID:
2525004
7.

[Effect of lentinan for advanced prostate carcinoma].

Tari K, Satake I, Nakagomi K, Ozawa K, Oowada F, Higashi Y, Negishi T, Yamada T, Saito H, Yoshida K.

Hinyokika Kiyo. 1994 Feb;40(2):119-23. Japanese.

8.

[Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].

Taguchi T.

Gan To Kagaku Ryoho. 1983 Feb;10(2 Pt 2):387-93. Japanese.

PMID:
6349538
9.

[TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].

Kimura Y, Iijima S, Kato T, Tsujie M, Naoi Y, Hayashi T, Tanigawa T, Yamamoto H, Kurokawa E, Matsuura N, Kikkawa N.

Gan To Kagaku Ryoho. 2003 Oct;30(11):1791-3. Japanese.

PMID:
14619521
11.

Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.

Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.

Cancer. 2001 Jun 15;91(12):2288-93.

PMID:
11413517
12.

[Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].

Nimura H, Mitsumori N, Tsukagoshi S, Nakajima M, Atomi Y, Suzuki S, Kusano M, Yoshiyuki T, Tokunaga A.

Gan To Kagaku Ryoho. 2003 Sep;30(9):1289-96. Japanese.

PMID:
14518408
13.

A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas.

Chen JS, Yang TS, Lin YC, Jan YY.

Jpn J Clin Oncol. 2003 Jul;33(7):353-6.

PMID:
12949062
14.

[Effects of endoscopic intratumoral injection of lentinan in patients with gastric cancer].

Inagaki T, Morise K, Matsunaga H.

Gan To Kagaku Ryoho. 1988 Feb;15(2):319-24. Japanese.

PMID:
3257678
15.

A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC).

Saito J, Nakai Y, Saijo Y, Nukiwa T, Koinumaru S, Matsuura Y, Aso N, Yamane Y, Tsukamoto T, Sayama T, Nakabayashi T.

Lung Cancer. 2001 Feb-Mar;31(2-3):285-93.

PMID:
11165409
16.

A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.

Gordon M, Bihari B, Goosby E, Gorter R, Greco M, Guralnik M, Mimura T, Rudinicki V, Wong R, Kaneko Y.

J Med. 1998;29(5-6):305-30.

PMID:
10503166
17.

[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].

Niimoto M, Hattori T, Itoh I, Tamada R, Inokuchi K, Orita K, Furue H, Ogawa N, Toda T, Furusawa M, Koga S, Hashimoto I, Kondo T, Fujimoto S, Sugiyama Y, Abe O, Ohya M.

Gan To Kagaku Ryoho. 1982 Dec;9(12):2133-47. Japanese.

PMID:
6820890
18.

Combination therapy with lentinan improves outcomes in patients with esophageal carcinoma.

Wang JL, Bi Z, Zou JW, Gu XM.

Mol Med Rep. 2012 Mar;5(3):745-8. doi: 10.3892/mmr.2011.718. Epub 2011 Dec 19.

PMID:
22200763
19.

A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.

Chen JS, Rau KM, Chen YY, Huang JS, Yang TS, Lin YC, Liau CT, Lee KD, Su YC, Kao RH.

Cancer Chemother Pharmacol. 2009 Apr;63(5):819-25. doi: 10.1007/s00280-008-0797-4. Epub 2008 Jul 29.

PMID:
18663448
20.

Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.

Uzcudun AE, Batlle JF, Velasco JC, Sánchez Santos ME, Carpeño Jde C, Grande AG, Juberías AM, Piñeiro EH, Olivar LM, García AG.

Dis Colon Rectum. 2002 Oct;45(10):1349-58.

PMID:
12394434

Supplemental Content

Support Center